1. Home
  2. PRDO vs TSHA Comparison

PRDO vs TSHA Comparison

Compare PRDO & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$34.00

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$6.46

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
TSHA
Founded
1994
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
PRDO
TSHA
Price
$34.00
$6.46
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$42.00
$11.63
AVG Volume (30 Days)
770.4K
2.8M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
1.75%
N/A
EPS Growth
10.50
5.56
EPS
1.60
N/A
Revenue
$581,296,000.00
$9,773,000.00
Revenue This Year
$4.28
N/A
Revenue Next Year
$2.89
$1,152.42
P/E Ratio
$38.18
N/A
Revenue Growth
N/A
17.28
52 Week Low
$26.66
$2.69
52 Week High
$38.50
$7.30

Technical Indicators

Market Signals
Indicator
PRDO
TSHA
Relative Strength Index (RSI) 48.66 57.18
Support Level $31.43 $5.28
Resistance Level $32.79 $6.76
Average True Range (ATR) 1.40 0.35
MACD 0.14 0.08
Stochastic Oscillator 60.07 83.46

Price Performance

Historical Comparison
PRDO
TSHA

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: